Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling. [electronic resource]
Producer: 20120427Description: 98-108 p. digitalISSN:- 1872-7980
- Antineoplastic Agents -- therapeutic use
- Ataxia Telangiectasia Mutated Proteins
- Benzenesulfonates -- therapeutic use
- Caffeine
- Carcinoma, Hepatocellular -- drug therapy
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- DNA-Binding Proteins -- antagonists & inhibitors
- Drug Screening Assays, Antitumor
- Drug Synergism
- Humans
- Liver Neoplasms -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyridines -- therapeutic use
- RNA, Small Interfering
- Signal Transduction -- drug effects
- Sorafenib
- Tumor Suppressor Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.